Resection of small bowel adenocarcinoma liver metastasis combined with neoadjuvant and adjuvant chemotherapy results in extended disease-free period - A case report

International Journal of Gastrointestinal Cancer

Volumn 37, Issue 2-3, 2006, Pages 94-97

  Eigenbrod, Tatjana ^a   Kullmann, Frank ^a   Klebl, Frank ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Adjuvant chemotherapy; Liver metastasis; Neoadjuvant chemotherapy; Small bowel adenocarcinoma

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADULT; ANAMNESIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE INTERVAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; JEJUNUM CANCER; LAPAROTOMY; LIVER METASTASIS; LIVER RESECTION; MULTIPLE CANCER; MULTIPLE CYCLE TREATMENT; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROCTOCOLECTOMY; SMALL INTESTINE CARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HEPATECTOMY; HUMANS; ILEAL NEOPLASMS; JEJUNAL NEOPLASMS; LEUCOVORIN; LIVER NEOPLASMS; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; PROGNOSIS;

EID: 35348861372     PISSN: 15373649     EISSN: 15590739     Source Type: Journal    
DOI: 10.1007/s12029-007-0005-5     Document Type: Article

References (17)

1. Gill SS, Heumann DM, Mihas AA. Small intestinal neoplasms. J Clin Gastroenterol 2001;33:267-82.
2. Hutchins RR, Hani AB, Kojodjojo P, Ho R, Snooks SJ. Adenocarcinoma of the small bowel. ANZ Journal of Surgery 2001;71:428-37.
3. Kariv R, Arber N. Malignant tumours of the small intestine - new insights into a rare disease. Isr Med Assoc J 2003;5:188-92.
4. Schmiegel W, Pox C, Adler G, Folsch UR, Fruhmorgen P, Graeven U, et al. S3-guidelines conference 'colorectal cancer.' Z Gastroenterol 2004;42:1129-77.
5. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors and outcome of 217 patients. Cancer 2004;101:518-26.
6. Onodera H, Nishitai R, Shimizu K, Maetani S, Imamura M. Small intestinal cancer with extensive lymph node metastases showing complete remission by methotrexate/5-fluorouracil sequential therapy: report of a case. Surg Today 1997;27:60-3.
7. Kummar S, Ciesielski TE, Fogarasi MC. Management of small bowel adenocarcinoma. Oncology 2002;16:1364-73.
8. Howe JR, Karnell LH, Menck HR, Scott-Conner C. The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. Cancer 1999;86:2693-706.
9. Ouriel K, Adams JT. Adenocarcinoma of the small intestine. Am J Surg 1984;147:66-71.
10. Crawley C, Ross P, Norman A, Hill A, Cunningham D. The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil. Br J Cancer 1998;78:508-10.
11. Gibson MK, Holcroft CA, Kvols LK, Haller D. Phase II study of 5-fluorouracil, doxorubicin and mitomycin C for metastatic small bowel adenocarcinoma. Oncologist 2005;10:132-7.
12. Locher C, Malka D, Boige V, Lebray P, Elias D, Lasser P, et al. Combination chemotherapy in advanced small bowel adenocarcinoma. Oncology 2005;69:290-4.
13. Polyzos A, Kouraklis G, Giannopoulos A, Bramis J, Delladetsima JK, Sfikakis PP. Irinotecan as salvage chemotherapy for advanced small bowel adenocarcinoma: a series of three patients. J Chemother 2003;15:503-6.
14. Goetz M, Erlichman C, Windebank AJ, Reid JM, Sloan JA, Atherton P, et al. Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, fluorouracil, and leucovorin in patients with solid tumors. J Clin Oncol 2003;21:3761-9.
15. Ychou M, Raoul J-L, Douillard J-Y, Bugat R, Mineur L, Viret F, et al. A phase III randomized trial of LV5FU2+CPT-11 vs. LV5FU2 alone in adjuvant high risk colon cancer (FNCLCC Accord02/FFCD9802). J Clin Oncol 2005;23 Suppl 16:3502.
16. Van Cutsem E, Labianca R, Hossfeld D, Bodoky G, Roth A, Aranda E, et al. Randomized phase III trial comparing infused irinotecan/5-fluorouracil (5-FU)/folinic acid (IF) versus 5-FU/FA (F) in stage III colon cancer patients (pts). (PETACC 3). J Clin Oncol 2005;23 Suppl 16:1090.
17. Lang H, Nadalin S, Raab R, Jahne J. Surgery treatment of primary adenocarcinoma of the duodenum. Chirurg 1999;70:571-7.